久久精品酒店无码视频_g∨天堂在线观看免费_av之高清在线_午夜福利资源片在线

浙江省科技型企業(yè)---加速您的多肽研究
首頁 >多肽產(chǎn)品 >Antisauvagine-30

多肽產(chǎn)品

220673-95-0,Antisauvagine-30,H2N-DPhe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2,H2N-DPhe-HLLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2,杭州專肽生物的產(chǎn)品

Antisauvagine-30

ASV-30 是一種構(gòu)象受限的 sauvagine 類似物,是一種針對小鼠 CRF 受體 2β (mCRFR2β) 的高效選擇性拮抗劑。它已被證明可抑制表達(dá) mCRFR2β 的人胚胎腎 (HEK) 293 細(xì)胞中激動劑誘導(dǎo)的腺苷酸環(huán)化酶活性。

編號:136970

CAS號:220673-95-0

單字母:H2N-fHLLRKMIEIEKQEKEKQQAANNRLLLDTI-CONH2

糾錯
  • 編號:136970
    中文名稱:Antisauvagine-30
    英文名:Antisauvagine-30
    英文同義詞:(D-Phe11,His12)-Sauvagine (11-40);11-D-Phenylalanine-12-L-histidine-11-40-sauvagine (11-40)
    CAS號:220673-95-0
    單字母:H2N-fHLLRKMIEIEKQEKEKQQAANNRLLLDTI-CONH2
    三字母:H2N

    N端氨基

    -DPhe

    D型笨丙氨酸

    -His

    組氨酸

    -Leu

    亮氨酸

    -Leu

    亮氨酸

    -Arg

    精氨酸

    -Lys

    賴氨酸

    -Met

    甲硫氨酸

    -Ile

    異亮氨酸

    -Glu

    谷氨酸

    -Ile

    異亮氨酸

    -Glu

    谷氨酸

    -Lys

    賴氨酸

    -Gln

    谷氨酰胺

    -Glu

    谷氨酸

    -Lys

    賴氨酸

    -Glu

    谷氨酸

    -Lys

    賴氨酸

    -Gln

    谷氨酰胺

    -Gln

    谷氨酰胺

    -Ala

    丙氨酸

    -Ala

    丙氨酸

    -Asn

    天冬酰胺

    -Asn

    天冬酰胺

    -Arg

    精氨酸

    -Leu

    亮氨酸

    -Leu

    亮氨酸

    -Leu

    亮氨酸

    -Asp

    天冬氨酸

    -Thr

    蘇氨酸

    -Ile

    異亮氨酸

    -CONH2

    C端酰胺化

    氨基酸個數(shù):30
    分子式:C161H274N48O46S1
    平均分子量:3650.26
    精確分子量:3648.03
    等電點(PI):10.33
    pH=7.0時的凈電荷數(shù):2.22
    平均親水性:0.46333333333333
    疏水性值:-0.76
    外觀與性狀:白色粉末狀固體
    消光系數(shù):-
    來源:人工化學(xué)合成,僅限科學(xué)研究使用,不得用于人體。
    純度:95%、98%
    鹽體系:可選TFA、HAc、HCl
    儲存條件:負(fù)80℃至負(fù)20℃
    標(biāo)簽:D型氨基酸肽   

  • ASV-30, a conformationally constrained analog of sauvagine, is a highly potent and selective antagonist directed against mouse CRF receptor type 2β (mCRFR2β). It has been shown to suppress agonist-induced adenylate cyclase activity in human embryonic kidney (HEK) 293 cells expressing mCRFR2β.

    Antisauvagine-30是一種選擇性、競爭性和強效的促腎上腺皮質(zhì)激素釋放因子CRF2受體拮抗劑,與大鼠CRF1和小鼠CRF2β受體結(jié)合的Kd值分別為153.6和1.4nM。它可以防止小鼠體內(nèi)應(yīng)激增強的恐懼條件和ERK1/2的MEK1/2依賴性激活。它抑制陰道刺激的cAMP在HEK-mCRF2β細(xì)胞中的積累。

    Antisauvagine-30 is a selective, competitive and potent corticotropin-releasing factor CRF2 receptor antagonist with Kd values of 153.6 and 1.4 nM for binding to rat CRF1 and mouse CRF2β receptors respectively. It prevents stress-enhanced fear conditioning and MEK 1/2-dependent activation of ERK1/2 in mice in vivo. It inhibits sauvagine-stimulated cAMP accumulation in HEK-mCRF2β cells.

    很多蛋白在細(xì)胞中非常容易被降解,或被標(biāo)記,進(jìn)而被選擇性地破壞。但含有部分D型氨基酸的多肽則顯示了很強的抵抗蛋白酶降解能力。

  • DOI名稱
    10.1111/j.1471-4159.2007.05052.xExpression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors下載
    10.1016/j.bbr.2011.03.026Wake-promoting effects of orexin: Its independent actions against the background of an impaired corticotropine-releasing hormone receptor system下載
    10.1073/pnas.95.26.15264Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30下載
  • 多肽H2N-DPhe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2的合成步驟:

    1、合成MBHA樹脂:取若干克的MBHA樹脂(如初始取代度為0.5mmol/g)和1倍樹脂摩爾量的Fmoc-Linker-OH加入到反應(yīng)器中,加入DMF,攪拌使氨基酸完全溶解。再加入樹脂2倍量的DIEPA,攪拌混合均勻。再加入樹脂0.95倍量的HBTU,攪拌混合均勻。反應(yīng)3-4小時后,用DMF洗滌3次。用2倍樹脂體積的10%乙酸酐/DMF 進(jìn)行封端30分鐘。然后再用DMF洗滌3次,甲醇洗滌2次,DCM洗滌2次,再用甲醇洗滌2次。真空干燥12小時以上,得到干燥的樹脂{Fmoc-Linker-MHBA Resin},測定取代度。這里測得取代度為 0.3mmol/g。結(jié)構(gòu)如下圖:

    2、脫Fmoc:取1.72g的上述樹脂,用DCM或DMF溶脹20分鐘。用DMF洗滌2遍。加3倍樹脂體積的20%Pip/DMF溶液,鼓氮氣30分鐘,然后2倍樹脂體積的DMF 洗滌5次。得到 H2N-Linker-MBHA Resin 。(此步驟脫除Fmoc基團(tuán),茚三酮檢測為藍(lán)色,Pip為哌啶)。結(jié)構(gòu)圖如下:

    3、縮合:取1.55mmol Fmoc-Ile-OH 氨基酸,加入到上述樹脂里,加適當(dāng)DMF溶解氨基酸,再依次加入3.1mmol DIPEA,1.47mmol HBTU。反應(yīng)30分鐘后,取小樣洗滌,茚三酮檢測為無色。用2倍樹脂體積的DMF 洗滌3次樹脂。(洗滌樹脂,去掉殘留溶劑,為下一步反應(yīng)做準(zhǔn)備)。得到Fmoc-Ile-Linker-MBHA Resin。氨基酸:DIPEA:HBTU:樹脂=3:6:2.85:1(摩爾比)。結(jié)構(gòu)圖如下:

    4、依次循環(huán)步驟二、步驟三,依次得到

    H2N-Ile-Linker-MBHA Resin

    Fmoc-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-Leu-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-Leu-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-His(Trt)-Leu-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    H2N-His(Trt)-Leu-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    Fmoc-DPhe-His(Trt)-Leu-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin

    以上中間結(jié)構(gòu),均可在專肽生物多肽計算器-多肽結(jié)構(gòu)計算器中,一鍵畫出。

    最后再經(jīng)過步驟二得到 H2N-DPhe-His(Trt)-Leu-Leu-Arg(Pbf)-Lys(Boc)-Met-Ile-Glu(OtBu)-Ile-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Glu(OtBu)-Lys(Boc)-Glu(OtBu)-Lys(Boc)-Gln(Trt)-Gln(Trt)-Ala-Ala-Asn(Trt)-Asn(Trt)-Arg(Pbf)-Leu-Leu-Leu-Asp(OtBu)-Thr(tBu)-Ile-Linker-MBHA Resin,結(jié)構(gòu)如下:

    5、切割:6倍樹脂體積的切割液(或每1g樹脂加8ml左右的切割液),搖床搖晃 2小時,過濾掉樹脂,用冰無水乙醚沉淀濾液,并用冰無水乙醚洗滌沉淀物3次,最后將沉淀物放真空干燥釜中,常溫干燥24小試,得到粗品H2N-DPhe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2。結(jié)構(gòu)圖見產(chǎn)品結(jié)構(gòu)圖。

    切割液選擇:1)TFA:H2O=95%:5%

    2)TFA:H2O:TIS=95%:2.5%:2.5%

    3)三氟乙酸:茴香硫醚:1,2-乙二硫醇:苯酚:水=87.5%:5%:2.5%:2.5%:2.5%

    (前兩種適合沒有容易氧化的氨基酸,例如Trp、Cys、Met。第三種適合幾乎所有的序列。)

    6、純化凍干:使用液相色譜純化,收集目標(biāo)峰液體,進(jìn)行凍干,獲得蓬松的粉末狀固體多肽。不過這時要取小樣復(fù)測下純度 是否目標(biāo)純度。

    7、最后總結(jié):

    杭州專肽生物技術(shù)有限公司(ALLPEPTIDE http://amynixphotography.com)主營定制多肽合成業(yè)務(wù),提供各類長肽,短肽,環(huán)肽,提供各類修飾肽,如:熒光標(biāo)記修飾(CY3、CY5、CY5.5、CY7、FAM、FITC、Rhodamine B、TAMRA等),功能基團(tuán)修飾肽(疊氮、炔基、DBCO、DOTA、NOTA等),同位素標(biāo)記肽(N15、C13),訂書肽(Stapled Peptide),脂肪酸修飾肽(Pal、Myr、Ste),磷酸化修飾肽(P-Ser、P-Thr、P-Tyr),環(huán)肽(酰胺鍵環(huán)肽、一對或者多對二硫鍵環(huán)),生物素標(biāo)記肽,PEG修飾肽,甲基化修飾肽等。

    以上所有內(nèi)容,為專肽生物原創(chuàng)內(nèi)容,請勿發(fā)布到其他網(wǎng)站上。

  • 暫時沒有數(shù)據(jù)